Idenix Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
September 28 2009 - 4:05PM
PR Newswire (US)
CAMBRIDGE, Mass., Sept. 28 /PRNewswire-FirstCall/ -- Idenix
Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that management
will present a corporate overview at the upcoming JMP Securities
Healthcare Focus Conference on Monday, October 5, 2009 at 8:30 a.m.
ET at The New York Palace Hotel. The live and archived webcast of
the company presentation can be accessed under "Calendar of Events"
in the Idenix Investor Center at http://www.idenix.com/. Please log
in approximately 5-10 minutes before the event to ensure a timely
connection. The archived replay will be available on the Idenix
website for two weeks following the conference. About Idenix Idenix
Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts,
is a biopharmaceutical company engaged in the discovery and
development of drugs for the treatment of human viral diseases.
Idenix's current focus is on the treatment of infections caused by
the hepatitis C virus. For further information about Idenix, please
refer to http://www.idenix.com/. Idenix Pharmaceuticals Contact:
Teri Dahlman (617) 995-9905 DATASOURCE: Idenix Pharmaceuticals,
Inc. CONTACT: Teri Dahlman, +1-617-995-9905 Web Site:
http://www.idenix.com/
Copyright
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jul 2023 to Jul 2024